July 11, 2019

Among teens treated in an emergency department for drug-related symptoms, those who used Spice, K2, or other synthetic cannabinoids were more likely to experience seizures and coma compared with those who used natural cannabis, researchers have found. “Synthetic cannabinoids, whether taken alone or with other substances, are associated with severe neuropsychiatric effects on adolescents and require […]

“I did not take this decision lightly,” Levine said in a statement. “For both conditions, medical marijuana is not first-line treatment and should not replace traditional therapies, but should be used in conjunction with them, when recommended by a physician.” … read more at: https://www.inquirer.com/business/weed/anxiety-marijuana-tourette-syndrome-pennsylvania-qualifying-conditions-20190711.html

Pete Buttigieg, a 2020 Democratic presidential candidate and the mayor of South Bend, Indiana, released a plan to address racial injustice on Thursday that includes proposals to dramatically reform federal drug laws. The “Douglass Plan,” named after historic abolitionist Frederick Douglass, aims to dismantle “racist structures and systems” in the country as well as make […]

COPENHAGEN (Reuters) – Danish cannabis firm StenoCare said on Thursday it would quarantine more batches of cannabis oil from its partner CannTrust which has sold products from what Canada’s federal health regulator called unlicensed facilities. StenoCare said it would now quarantine five batches of the oil, up from just one yesterday. “The most likely consequence […]

Under the U.S. Drug Enforcement Administration’s (DEA) Controlled Substance Act (CSA), drugs are classified into five distinct schedules depending upon their acceptable medical use and their overall potential for abuse or dependency. The DEA currently lists cannabis as a Schedule I drug, which the CSA defines as drugs having no currently accepted medical use and […]

First order shipped to Saskatchewan; purchase orders for other provinces and retailers imminent. Toronto, Ontario–(Newsfile Corp. – July 11, 2019) – Beleave Inc. (CSE: BE) (OTCQX: BLEVF) (“Beleave” or the “Company“) today announced that it has commenced sales of the Company’s cannabis oils for the Canadian adult use market, with product expected to hit store […]

Few companies epitomise the challenges of their industry better than GlaxoSmithKline (GSK). For years, the UK’s biggest drugs company has battled with its need to innovate, while attempting to cling onto the strategy that made it one of the most profitable businesses in the world. It’s a problem that is mirrored across the entire global pharmaceutical […]

Fundamentals of US Regulatory Affairs, 11th Edition For 20 years, our flagship publication, Fundamentals of US Regulatory Affairs, has been giving regulatory professionals the insights and answers they need, right at their fingertips. BUY NOW … read more at: https://www.raps.org/news-and-articles/news-articles/2019/7/recon-trump-pulls-plan-to-eliminate-certain-drug

MGC Pharmaceuticals’ seed-to-pharmacy strategy is picking up significant momentum with the ASX-listed company reporting revenues of $763,000 in the fourth quarter ended 30 June 2019. Notably, this is well above the sales revenue of $296,811 that it recorded in the entire 2017-2018 financial year. The result is due, in part, to the receipt of $469,000 […]

© iStock/shapecharge Therapix is a clinical-stage pharmaceutical company focused in creating a portfolio of technologies and assets based on cannabinoid products. Therapix Biosciences Ltd. is a speciality clinical-stage pharmaceutical company. Led by an experienced team of Senior Executives and Scientists Therapix Biosciences Ltd. has a vision to connect cannabinoid products to the healthcare system to […]